Biomimix, Inc. is commercializing products and technologies based upon biomimicry – modeling nature’s processes, systems and elements to solve complex problems and address large unmet medical needs. The Company will invest in high-potential product development, licensing and joint venture partnerships to advance products to market. Biomimix is focused on medical device applications, drug development programs including OTC products, and targeted platform technologies serving niche indications which present high commercial potential. The Company will acquire marketed products and services where Biomimix can leverage sales and marketing and distribution channel expertise to drive revenue growth.
703-889-8332
rob@k2pr.net